Adjusted analysis | Unadjusted analysis | |||||||
CRAE (µm) | CRVE (µm) | CRAE (µm) | CRVE (µm) | |||||
Beta coefficient (95% CI) | P values | Beta coefficient (95% CI) | P values | Beta coefficient (95% CI) | P values | Beta coefficient (95% CI) | P values | |
Age | – | – | – | – | 0.39 (−0.21 to 0.30) | 0.694 | −0.62 (−0.33 to 0.17) | 0.534 |
Female | – | – | – | – | 1.62 (−0.91 to 9.67) | 0.105 | 0.90 (−2.88 to 7.76) | 0.369 |
Duration of vertigo attacks | 0.77 (−2.21 to 5.08) | 0.441 | −2.22 (−7.51 to 0.47) | 0.014 | 0.90 (−1.98 to 5.32) | 0.370 | −2.15 (−7.34 to 0.34) | 0.032 |
Frequency of vertigo attacks | 3.19 (1.44 to 6.03) | 0.001 | −0.30 (−2.88 to 2.11) | 0.761 | 3.27 (1.54 to 6.12) | 0.001 | −0.22 (−2.75 to 2.19) | 0.824 |
Migraine | 2.36 (1.12 to 12.16) | 0.018 | 0.03 (−5.71 to 5.87) | 0.979 | 2.83 (2.27 to 12.48) | 0.28 | 0.28 (−4.61 to 6.17) | 0.78 |
Age and sex were adjusted in the adjusted model.
AVR, artery:vein ratio; CRAE, central retinal artery equivalent; CRVE, central retinal vein equivalent; MD, Meniere’s disease.